Cabozantinib and Pembrolizumab in Metastatic Pancreas

Clinical trial NCT05052723 · COMPLETED

Trial details

NCT number: NCT05052723
Sponsor: Joseph Kim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2022-01-04
Primary completion: 2024-11-05
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.